title: The treatment of pharyngeal gonorrhoea with a single oral dose of cefixime.
abstract: An audit of the efficacy treatment of pharyngeal gonorrhoea with a single oral dose of 400 mg of cefixime was undertaken; 83% of patients also received a single oral dose of azithromycin to treat possible concurrent anogenital chlamydial infection. Of the 54 patients studied, only one of 45 patients who attended for at least one test of cure had a positive culture seven days after treatment; the possibility of reinfection could not have been excluded. Two tests of cure were obtained from 18 patients. Cefixime, therefore, seems to be effective in the treatment of pharyngeal gonorrhoea.
authors.affiliation: Department of Genitourinary Medicine, NHS Lothian University Hospitals Division, Edinburgh, UK. a.amcmm@btopenworld.com
authors.forename: A
authors.initials: A
authors.lastname: McMillan
authors.forename: H
authors.initials: H
authors.lastname: Young
mesh_terms: D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D020682:Cefixime / Q000008:administration & dosage*; D002690:Chlamydia Infections / Q000150:complications / Q000188:drug therapy; D002692:Chlamydia trachomatis / Q000187:drug effects; D004334:Drug Administration Schedule; D005260:Female; D006069:Gonorrhea / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008485:Medical Audit; D010614:Pharynx / Q000382:microbiology*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D020682:Cefixime